Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Update README.md #136

Merged
merged 1 commit into from
Feb 2, 2024
Merged
Changes from all commits
Commits
File filter

Filter by extension

Filter by extension

Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
4 changes: 2 additions & 2 deletions README.md
Original file line number Diff line number Diff line change
Expand Up @@ -26,7 +26,7 @@ PK-Sim® uses building blocks that are grouped into [**Individuals**](https://do

### MoBi

[MoBi®](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation) is a systems biology software tool for multiscale physiological modeling and simulation. Within the restrictions of ordinary differential equations, almost any kind of (biological) model can be imported or set up from scratch. Examples include biochemical reaction networks, compartmental disease progression models, or PBPK models. However, the de novo development of a PBPK model, for example, is very cumbersome such that the preferred procedure is to import them from PK-Sim®. Importantly, MoBi® also allows for the combination of the described examples and thereby is a very powerful tool for modeling and simulation of multiscale physiological systems covering molecular details on the one hand and whole-body architecture on the other hand.
[MoBi®](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation) is a systems biology software tool for multiscale physiological modeling and simulation. Within the restrictions of ordinary differential equations, almost any kind of (biological) model can be imported or set up from scratch. Examples include *in vitro* dissolution testing, biochemical reaction networks, compartmental disease progression models, or PBPK models. However, the de novo development of a PBPK model, for example, is very cumbersome such that the preferred procedure is to import it from PK-Sim®. Importantly, MoBi® also allows for the combination of the described examples and thereby is a very powerful tool for modeling and simulation of multiscale physiological systems covering molecular details on the one hand and whole-body architecture on the other hand.

De novo model establishment and simulation is supported by graphical tools and building blocks to support expert users. MoBi® uses building blocks that are grouped into [**Molecules**](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/model-building-components#molecules), [**Reactions**](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/model-building-components#reactions), [**Spatial Structures**](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/model-building-components#spatial-structures), [**Passive Transports**](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/model-building-components#transport-processes), [**Observers**](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/model-building-components#observers), [**Events**](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/model-building-components#events-and-applications), [**Molecule Start Values**](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/model-building-components#molecule-start-values), [**Parameter Start Values**](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/model-building-components#parameter-start-values) and [**Observed Data**](https://docs.open-systems-pharmacology.org/shared-tools-and-example-workflows/import-edit-observed-data). Building blocks out of the above-mentioned groups can be combined to [generate models](https://docs.open-systems-pharmacology.org/working-with-mobi/mobi-documentation/setting-up-simulation). The advantage of building blocks is that they can be reused. Examples:

Expand All @@ -35,7 +35,7 @@ De novo model establishment and simulation is supported by graphical tools and b

### Qualification framework

The qualification framework enables an automated validation of various scenarios (use-cases) supported by the OSP platform. This technical framework is used, for example, to release, in full confidence, a new version of the OSP Suite by verifying automatically that an ever-growing list of scenarios is performing as expected. Qualification framework is described in detail [here](https://docs.open-systems-pharmacology.org/shared-tools-and-example-workflows/qualification).
The qualification framework enables an automated validation of various scenarios (use-cases) supported by the OSP platform. This technical framework is used, for example, to release, in full confidence, a new version of the OSP Suite by verifying automatically that an ever-growing list of scenarios is performing as expected. The qualification framework is described in detail [here](https://docs.open-systems-pharmacology.org/shared-tools-and-example-workflows/qualification).

### Validation and automation tools

Expand Down
Loading